Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
11 Mar 2024
Historique:
medline: 14 3 2024
pubmed: 13 3 2024
entrez: 12 3 2024
Statut: epublish

Résumé

Randomised controlled trials (RCTs) inform healthcare decisions. It is now apparent that some published RCTs contain false data and some appear to have been entirely fabricated. Systematic reviews are performed to identify and synthesise all RCTs that have been conducted on a given topic. While it is usual to assess methodological features of the RCTs in the process of undertaking a systematic review, it is not usual to consider whether the RCTs contain false data. Studies containing false data therefore go unnoticed and contribute to systematic review conclusions. The INveStigating ProblEmatic Clinical Trials in Systematic Reviews (INSPECT-SR) project will develop a tool to assess the trustworthiness of RCTs in systematic reviews of healthcare-related interventions. The INSPECT-SR tool will be developed using expert consensus in combination with empirical evidence, over five stages: (1) a survey of experts to assemble a comprehensive list of checks for detecting problematic RCTs, (2) an evaluation of the feasibility and impact of applying the checks to systematic reviews, (3) a Delphi survey to determine which of the checks are supported by expert consensus, culminating in, (4) a consensus meeting to select checks to be included in a draft tool and to determine its format and (5) prospective testing of the draft tool in the production of new health systematic reviews, to allow refinement based on user feedback. We anticipate that the INSPECT-SR tool will help researchers to identify problematic studies and will help patients by protecting them from the influence of false data on their healthcare. The University of Manchester ethics decision tool was used, and this returned the result that ethical approval was not required for this project (30 September 2022), which incorporates secondary research and surveys of professionals about subjects relating to their expertise. Informed consent will be obtained from all survey participants. All results will be published as open-access articles. The final tool will be made freely available.

Identifiants

pubmed: 38471680
pii: bmjopen-2024-084164
doi: 10.1136/bmjopen-2024-084164
pmc: PMC10936473
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e084164

Subventions

Organisme : NEI NIH HHS
ID : UG1 EY020522
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: JW, CH, GAA, LB and JJK declare funding from NIHR (NIHR203568) in relation to this work. JW additionally declares stats or methodological editor roles for BJOG, Fertility and Sterility, Reproduction and Fertility, Journal of Hypertension and for Cochrane Gynaecology and Fertility. CH declares a statistical editor role for Cochrane Colorectal. LB additionally declares a role as academic meta-research editor for PLoS Biology, and that The University of Colorado receives remuneration for service as senior research integrity editor, Cochrane. JJK additionally declares a statistical editor role for The BMJ. WL, LS and RW declare funding from Australian National Health and Medical Research Council Investigator Grants (GNT2016729, GNT2009432, GNT2009767). LS additionally declares roles as editorial board member for Cochrane Evidence Synthesis Methods and statistical editor for Cochrane Neonatal Group. RW additionally declares roles as deputy editor for Human Reproduction and editorial board member for BJOG and Cochrane Gynaecology and Fertility. WL additionally declares roles of associate editor for Human Reproduction Open and methodological editor for Fertility and Sterility and Fertility and Sterility Reviews. EF, SG and TLasserson declare employment by Cochrane. EF additionally declares a role as editorial board member for Cochrane Synthesis and Methods. TLasserson additionally declares authorship of a chapter in the Cochrane Handbook for Systematic Reviews of Interventions and that he is a developer of standards for Cochrane Intervention Reviews (MECIR). SG additionally declares an academic editor role for PLOS Global Public Health. ES declares that she was a member of the Cochrane scientific misconduct policy advisory group, and roles as sign-off editor and proposal editor of The Cochrane Library. ZA declares he is a member of the Cochrane Library Editorial Board, was co-ordinating editor for Cochrane Pregnancy and Childbirth Group 2002–2023 and is PI on a grant from Children Investment Foundation Fund to University of Liverpool to investigate research integrity of clinical trials related to nutritional supplements in pregnancy. TLi is supported by grant UG1 EY020522 from the National Eye Institute, National Institutes of Health. TLi also declares roles as editor-in-chief for Trials, statistical editor for Annals of Internal Medicine, review editor for JAMA Ophthalmology and editorial board member for Journal of Clinical Epidemiology. MC declares that he is Co-ordinating editor for the Cochrane Methodology Review Group, Editor in Chief of Journal of Evidence-Based Medicine, and Co-ordinating Editor of the James Lind Library. AA declares that The Health Services Research Unit, University of Aberdeen, is funded by the Health and Social Care Directorates of the Scottish Government. All other authors declare no competing interests. DT declares an RCT topic editor role for Research Methods in Medicine and Health Sciences. MvW declares roles as co-ordinating editor for Cochrane Gynaecology and Fertility and Sexually Transmitted Infections, methodology editor for Human Reproduction Update and editorial editor for Fertility and Sterility. NEO declares roles as co-ordinating editor for Cochrane Pain, Palliative and Supportive Care (PaPaS) Group, 2020–2023, as member of Cochrane Central Editorial Board and as editorial board member for Journal of Pain. JC declares an editor role for Anaesthesia. AL declares a role as editorial board member for BMC Medical Ethics. GAA declares a role as statistical editor for the European Journal of Vascular and Endovascular Surgery. NJLB declares roles as editorial board member for International Review of Social Psychology/Revue Internationale de Psychologie Sociale, statistical advisory board member for Mental Health Science and advisory board member for Meta-Psychology. BWM declares roles as editor for Cochrane Gynaecology and Fertility and Sexually Transmitted Infections and for Fertility and Sterility. SL declares roles as associate editor for Human Reproduction, methodological editor for Fertility and Sterility and editor for Cochrane Gynaecology and Fertility. EL is head of research and clinical editor for The BMJ.

Références

Arch Intern Med. 2006 Jun 26;166(12):1256-61
pubmed: 16801507
Cochrane Database Syst Rev. 2020 Aug 12;8:CD007407
pubmed: 32794606
Cochrane Database Syst Rev. 2021 Jun 3;6:ED000152
pubmed: 34081324
Res Synth Methods. 2023 May;14(3):357-369
pubmed: 36054583
Open Forum Infect Dis. 2021 Jul 06;8(11):ofab358
pubmed: 34796244
BJOG. 2016 Oct;123(11):1745-52
pubmed: 27558956
Open Forum Infect Dis. 2022 Jan 17;9(2):ofab645
pubmed: 35071686
J Clin Epidemiol. 2021 Aug;136:189-202
pubmed: 34033915
J Clin Epidemiol. 2022 Nov;151:1-17
pubmed: 35850426
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Res Integr Peer Rev. 2023 Jun 20;8(1):6
pubmed: 37337220
BMJ. 2008 May 3;336(7651):995-8
pubmed: 18456631
JAMA Intern Med. 2018 Aug 1;178(8):1135
pubmed: 30083732
Nat Med. 2021 Nov;27(11):1853-1854
pubmed: 34552263
Am J Ther. 2021 Jun 21;28(4):e434-e460
pubmed: 34145166
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Nature. 2020 Jan;577(7789):167-169
pubmed: 31911697

Auteurs

Jack Wilkinson (J)

Centre for Biostatistics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK jack.wilkinson@manchester.ac.uk.

Calvin Heal (C)

Centre for Biostatistics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

George A Antoniou (GA)

Manchester Vascular Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Division of Cardiovascular Sciences, School of Medical Sciences, Manchester Academic Health Science Centre, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK.

Ella Flemyng (E)

Evidence Production and Methods Directorate, Cochrane, London, UK.

Zarko Alfirevic (Z)

Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.

Alison Avenell (A)

Health Services Research Unit, University of Aberdeen, Aberdeen, UK.

Ginny Barbour (G)

Medical Journal of Australia, Sydney, New South Wales, Australia.

Nicholas J L Brown (NJL)

Department of Psychology, Linnaeus University, Växjö, Sweden.

John Carlisle (J)

Anaesthesia and Critical Care, Torbay Hospital, Torquay, UK.

Mike Clarke (M)

Northern Ireland Methodology Hub, Queen's University Belfast, Belfast, UK.

Patrick Dicker (P)

Department of Epidemiology and Public Health, Royal College of Surgeons in Ireland, Dublin, Ireland.

Jo C Dumville (JC)

Division of Nursing, Midwifery and Social Work, School of Health Sciences, The University of Manchester, Manchester, UK.
NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Andrew Grey (A)

Department of Medicine, University of Auckland, Auckland, New Zealand.

Steph Grohmann (S)

Evidence Production and Methods Directorate, Cochrane, London, UK.

Lyle Gurrin (L)

School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Jill Alison Hayden (JA)

Community Health & Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada.
Department of Community Health & Epidemiology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

James Heathers (J)

SafeBeat Rx Inc, St Louis, Missouri, USA.

Kylie Elizabeth Hunter (KE)

Evidence Integration, NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.

Toby Lasserson (T)

Evidence Production and Methods Directorate, Cochrane, London, UK.

Emily Lam (E)

Independent Lay Member, Cheshire, UK.

Sarah Lensen (S)

Department of Obstetrics and Gynaecology, Royal Women's Hospital, University of Melbourne, Melbourne, Victoria, Australia.

Tianjing Li (T)

Department of Ophthalmology, University of Colorado, Denver, Colorado, USA.

Wentao Li (W)

Department of Obstetrics and Gynecology, Monash University, Clayton, Victoria, Australia.

Elizabeth Loder (E)

BMJ Publishing, London, UK.
Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Andreas Lundh (A)

Centre of Evidence-Based Medicine Odense and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Department of Respiratory Medicine and Infectious Diseases, Copenhagen University Hospital-Bispebjerg and Frederiksberg, Kobenhavn, Denmark.

Gideon Meyerowitz-Katz (G)

School of Health and Society, University of Wollongong, Wollongong, New South Wales, Australia.

Ben W Mol (BW)

Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.

Neil E O'Connell (NE)

Department of Clinical Science, Brunel University, Uxbridge, UK.
Centre for Health and Wellbeing across the Lifecourse, Dept of Health Sciences, Brunel University, London, UK.

Lisa Parker (L)

School of Pharmacy, Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.

Barbara K Redman (BK)

Division of Medical Ethics, New York University Grossman School of Medicine, New York, New York, USA.

Lene Seidler (L)

Evidence Integration, NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.

Kyle A Sheldrick (KA)

Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

Emma Sydenham (E)

Cochrane Central Production Service, Cochrane, London, UK.

David Torgerson (D)

York Trials Unit, Dept of Health Sciences, University of York, York, UK.

Madelon van Wely (M)

Cochrane Gynaecology and Fertility Satellite and Cochrane Sexually Transmitted Infection Group, Cochrane, Duivendrecht, The Netherlands.
Reproduction and Development Research Institute, Amsterdam University Medical Center, Amsterdam, The Netherlands.

Rui Wang (R)

Department of Obstetrics and Gynaecology, Monash University, Clayton, Victoria, Australia.

Lisa Bero (L)

Center for Bioethics and Humanities, University of Colorado-Anschutz Medical Campus, Denver, Colorado, USA.

Jamie J Kirkham (JJ)

Centre for Biostatistics, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH